chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presented to clinic for a well child check, returning  to the state  (after living out of state). MA gave Kinrix and MMRV per MN MIIC. After both combination vaccinations were given with parental consent, mother provided a vaccination record noting that he was up to date on his DTaP, MMR, and varicella. He was due for his 4th IPV dose.  With giving Kinrix and MMRV, he got extra doses of the MMR and varicella. He also got a dose of DTaP that he was not due for and due to his age should have been switched to Tdap. This is a vaccine administration error and no adverse effects were noted. No additional care was needed. Patient's mother was contacted after the visit to notify her what happened.
Right after vaccination administered patient felt her throat felt "tingly and numb". Lips started to feel tingly. Felt lightheaded and dizzy. Said she tasted "mercury" in her mouth.
arm soreness within an hour, night chills within 6 hours, fever within 12 hours, delayed/missed menstrual cycle.
Received Covid-19 vaccine on March 18 following temperature excursion; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Covid-19 vaccine on March 18 following temperature excursion) in a 22-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Covid-19 vaccine on March 18 following temperature excursion). On 18-Mar-2021, EXPIRED PRODUCT ADMINISTERED (Received Covid-19 vaccine on March 18 following temperature excursion) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No concomitant medications were reported. No treatment related information has been reported.
Two weeks post vax, the pt experienced alopecia of the eyebrows and eyelashes bilaterally. Currently, her eyebrows and eyelashes are very thin. The most recent information received reports the outcome of the event as ongoing.
This spontaneous report was received from nurse practitioner and refers to a 42 year old female patient. The patient had no pertinent medical history and concomitant medication. The patient had allergy to "sulfa". On an unknown date in childhood, the patient received a dose of M-M-R II (dose, route of administration, lot number and expiration date were not provided) for prophylaxis. On an unknown date, for an unknown reason the patient had titers tested for M-M-R II with a result of negative. In May 2013, the patient received another dose of M-M-R II (dose, route of administration and expiration date were not provided) , lot number H013040 (also reported as lot number H013046), for prophylaxis. In June 2013, the patient received the next dose of M-M-R II (dose, route of administration, lot number and expiration date were not provided) for prophylaxis. On 10-AUG-2016, the patient had titers tested with a result of positive. On approximately 29-MAR-2017 (reported as 2 weeks ago), the patient had titers tested with a result of negative. There was an unspecified treatment given for an adverse events. There was no product quality complaint involved in this case. The outcome of the events was unknown. The relatedness between the events and vaccination with M-M-R II was not reported. Lot number H013046 was considered to be not valid for M-M-R II. Additional information has been requested.
A clicking sensation and a popping sensation with range of motion in the right arm; Right shoulder pain; Slight nausea; Headache; Slight dizziness; Redness over his right upper arm; This spontaneous case was reported by a nurse and describes the occurrence of CREPITATIONS (A clicking sensation and a popping sensation with range of motion in the right arm), DIZZINESS (Slight dizziness), ERYTHEMA (Redness over his right upper arm), ARTHRALGIA (Right shoulder pain) and NAUSEA (Slight nausea) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced DIZZINESS (Slight dizziness), ERYTHEMA (Redness over his right upper arm), NAUSEA (Slight nausea) and HEADACHE (Headache). On an unknown date, the patient experienced CREPITATIONS (A clicking sensation and a popping sensation with range of motion in the right arm) and ARTHRALGIA (Right shoulder pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, CREPITATIONS (A clicking sensation and a popping sensation with range of motion in the right arm), DIZZINESS (Slight dizziness), ERYTHEMA (Redness over his right upper arm), ARTHRALGIA (Right shoulder pain), NAUSEA (Slight nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided.
Information has been received from a female pt who was vaccinated "as a child" with a dose of MMRII (Lot # not reported). In 2003 a titer was drawn and showed she is non-reactive to rubella. Unspecified medical attention was sought.  Additional information has been requested.
Chills; pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PAIN (pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills) and PAIN (pain). At the time of the report, CHILLS (Chills) and PAIN (pain) outcome was unknown.            No concomitant and treatment medications were provided by reporter.
A non-serious report of administered expired FLUMIST was received from a medical assistant concerning a 36-month-old female. FLUMIST, which expired on 25-Dec-2008, was administered on 26-Dec-2008. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. This case is submitted in accordance with a post-marketing commitment on accelerated reporting of 2 years to 59 months of age for FLUMIST. Based on the results on the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the prouduct expired. Additional information received on 03-Feb-2009 included Product Complaint Investigation results.
Large local reaction to AVA #5. Redness, tenderness, induration and pain extends 5 inches beyond injection site.
PATIENT RECIEVED TWO DOSES OF PFIZER COVID VACCINE ON THE CLINIC DAY BY SEPERATE NURSES.
Burning at injection site (R upper arm). For 2 days unable to raise arm. Severe pain to raise arm 2 months later - As of today hurts when raising 1/2 up hurts badly at shoulder level (stiffness). The injection has been 2 months - as of today I can hardly move my arm.
Moderna COVID?19 Vaccine EUA  Bells Palsy of left side of face. Noticed a few days afterward, increased in intensity for a few days following.   Still experiencing.
Patient was given Pfizer as her first dose at another location but was given Moderna as her second at another facility. Patient was held for 30 minutes and reported that she felt fine. Moderna was contacted for directives. Per Moderna, patient does not need any other doses and patient was informed.
Vaccine variant varicella starting 3/29/2006 at least 50-100 spots.
case tested on 4/23 and was admitted. currently in an ICU bed and wanting to talk to anyone
This spontaneous report was received from a pharmacist regarding a patient of unknown demographics. There was no information was concurrent condition and historical medications. On 21-SEP-2017, the patient was vaccinated with improperly stored ZOSTAVAX lot # M020902/ expiration date- 18-JUL-2017. Temperature was 6.7 F(Fahrenheit), temperature was 30 minutes and call was not because of the data logger. Previous temperature excursion was 12 F for 2 hours. No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. No PCQ (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
No immediate side effects or symptoms following vaccination on January 20. January 31, 2021: large hive at site of injection, approximately 2-inches across and itchy. Followed by red rash, "petechiae" at site of injection.  February 1, 2021: petechiae clusters appear on left and right arms, chest, and legs. Unexplained bruises appear on arms and legs. February 3, 2021: primary care doctor sends patient to emergency department. Emergency department runs a complete blood count, finding platelet levels at 23,000. Patient is admitted to Hospital overnight. February 4, 2021: patient begins five-day course of dexamethasone, 40mg/daily.  Patient's platelet levels test at 63,000 15 hours after first dose of dexamethasone. February 5, 2021: patient is discharged from hospital. February 8, 2021: patient completes course of dexamethasone.
This medically confirmed spontaneous report (initial receipt: 27-Sep-2012) concerns a 27-year-old female patient. On 26-Sep-2012 the patient received AFLURIA (batch number: P59608) injection at a dose of 0.5 mL once intramuscularly. On 26-Sep-2012, after receiving a dose of AFLURIA, the patient developed muscle pain and stiffness on her neck and some pain in the arm of the injection site. She stated that the pain was along the spine of her neck. The patient sought medical attention. The event outcome was recovering.
Bell's palsy/facial paralysis; This is a spontaneous report from a contactable other Health Professional (patient). A 28-years-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/ batch number: 33121, brand: EJ1685), via an unspecified route of administration at left arm on 18Dec2020 09:30 at single dose for covid-19 immunization at hospital. Medical history included anxiety, depression, diagnosed COVID-19 prior vaccination. No known allergies. Concomitant medication included fluoxetine hydrochloride (PROZAC) in two weeks. No other vaccine in four weeks. The patient experienced bell's palsy/facial paralysis on 21Dec2020 19:00 with outcome of not recovered. The seriousness was reported as no. The adverse event result in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The treatment received for the adverse event was reported as unknown.; Sender's Comments: Based on available information, a possible contributory role of the subject vaccine cannot be excluded for the reported event of Bell's palsy due to temporal relationship. However, the reported event may possibly represent intercurrent medical condition in this patient. There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications.   This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
diarrhea; Muscle pain; nausea; headache; fever; A spontaneous report ( was received from a consumer concerning a 61-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events muscle pain, nausea, diarrhea, headache, fever.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 27 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 001A210A) intramuscularly for prophylaxis of COVID-19 infection.  On 28 Feb 2021, the patient experienced the event(s) muscle pain, nausea, diarrhea, headache, fever.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), muscle pain, nausea, diarrhea, headache, fever was unknown.
hard round bump about the size of a nickel w/red blotchy area 4 3/4 x 5" which is hot to touch on lt thigh; does not want to run;
red like a rash; its about 4 inches down to my injection site and its warm to touch; red like a rash /its going down to my arm; more prominent than it was before; about 4 inches down to my injection site; lump; discomfort where I got the vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of MASS (lump), VACCINATION SITE DISCOMFORT (discomfort where I got the vaccine), RASH ERYTHEMATOUS (red like a rash), FEELING HOT (its about 4 inches down to my injection site and its warm to touch) and RASH (red like a rash /its going down to my arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced MASS (lump) and VACCINATION SITE DISCOMFORT (discomfort where I got the vaccine). On 09-Apr-2021, the patient experienced RASH ERYTHEMATOUS (red like a rash), FEELING HOT (its about 4 inches down to my injection site and its warm to touch), RASH (red like a rash /its going down to my arm), RASH (more prominent than it was before) and VACCINATION SITE RASH (about 4 inches down to my injection site). At the time of the report, MASS (lump), VACCINATION SITE DISCOMFORT (discomfort where I got the vaccine), RASH ERYTHEMATOUS (red like a rash), FEELING HOT (its about 4 inches down to my injection site and its warm to touch), RASH (red like a rash /its going down to my arm), RASH (more prominent than it was before) and VACCINATION SITE RASH (about 4 inches down to my injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported.  Treatment details include, ice, antihistamines.
"41mins post vaccination, pt c/o throat numbness.  Pt had left observation and went to his car but came back to clinic d/t throat numbness. Pt A&Ox4, speaks in full sentences, lungs clear, VSS, no difficulty breathing, can swallow. Vitals: @17:31 BP 144/99, HR 69, RR 18, O2 Sat 100% on RA -- > @17:38 136/89, 65,18, 100% on RA.   Pt condition remains the same. ED precautions discussed.  He states that he is ok to go home. Pt verbalized understanding on ED precautions.  Pt stable and released from the vaccination site @17:41. NO PMH or medication list available to this writer."
Patient experience some dizziness and chest tightness approximately 10 minutes after vaccination. She was told to stay seated, cold compress administered and benadryl 2 teaspoons taken. She improved after resting and drinking water and was examined by EMT. She refused to go with EMT and stated she felt better. Patient was able to speak and respond throughout.
Head ache, feaver, muscle cramps, muscle pain, chest pain (possible pericarditis), shortness of breath, fatigue
Symptoms: Vomiting, vision acuity changes, back pain, nausea, dizziness, headache, body aches.  Initial symptoms showed up at noon with progression and persistence to the next day. Patient is still seeking medical treatment at this time.
Hard "knot" at injection site. Warm to touch. Pain radiating up to neck started in 24 hours after injection and lasted 3 days.
Shortness of breath; chest pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DYSPNOEA (non-serious), outcome "unknown", described as "Shortness of breath"; CHEST PAIN (non-serious), outcome "unknown", described as "chest pain".  Additional information: Shortness of breath and chest pain after Pfizer vaccine. Was not sure that was just what the oxygen oximeter done. Patient went to a cardiologist so that patient could get more answers.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Arm aches feels like muscle pain, soreness. Arm and shoulder extremely sore, can't use it to do simple things. It's been almost 2 months, I can't sleep on that arm it hurts so much!
Red macular rash on both arms and trunk with warmth. No itching. No large swelling. Not considered adverse: had routine low grade fever for 1 day and mild myalgia.
Pain in shoulder joint esp. with abduction, limited shoulder ROM continuing 3 weeks after injection requiring physical therapy and prednisone taper.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 71-year-old female patient who received SHINGRIX (batch number 32GR4 ?, expiry date 4th July 2020). Concomitant products included ADVAIR and Blood Pressure Medication. On 23rd May 2018, the patient received the 1st dose of SHINGRIX. On 23rd May 2018, less than a day after receiving SHINGRIX, the patient experienced pain in arm, chills, fatigue and headache. On an unknown date, the outcome of the pain in arm, chills, fatigue and headache were not recovered/not resolved. The reporter considered the pain in arm, chills, fatigue and headache to be related to SHINGRIX. Additional details were provided as follows: The concomitant drug included anxiety medication. The caller was pharmacist reporting that one of his patients received 1st dose of SHINGRIX yesterday that is 23rd May 2018 and was reporting to be experiencing arm pain, headache, chills and overall fatigue.
Client vaccinated with Pfizer vaccines for Covid in December 2020 and January 2021.  Boosted in early December 2021.  Symptoms started 12/22/2021 - nasal congestion, fatigue, headache, myalgia.
Severe neck pain and head ache. Pain was so intense I could not lift my head up off a pillow. Pain was 10/10 (0-10 scale) and is currently a 6/10 with persistent unrelenting squeezing "like a vice" type pain. OTC pain reliever has not worked. Severe nausea present throughout. Severe ocular pain, photophobia and ocular pressure.
The night after the shot I developed COVID arm which burned and itched and swelled up. The next night a rash spread to my arms and trunk. The next night my right leg swelled up horribly and got a rash as well on my upper quad. My eyes burned for days after the shot and my eye doctor said my eye lids were inflamed and gave me steroid eye drops to help. The next night I woke up in the middle of the night itching my face. My whole face was covered in a rash that burned and was swollen. I had 4mg pills of methylpredisolone on hand at home and self treated with three pills (one each day for three days) and that helped with the swelling and Benedryl helped with the itching. I started having heavier periods at increments more than once a month (like once a week). I also have experienced significant weight gain - almost 10 pounds - in the month after the shot. I have weighed the same thing since I was in college and still wear the same clothes until after the shot. The periods have subsided but the weight is still here and I've done nothing else differently.
first dose of Shingrix vaccine 10/25/18 and the second dose today.; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 25th October 2018).   On 25th August 2021, the patient received the 2nd dose of Shingrix. On 25th August 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 2nd dose of Shingrix later than the recommended interval, which led to lengthening of vaccine schedule. The reporter did not consent to follow up. This case has been linked with case US2021179654, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021179654:Same reporter
Nurse (MA) gave pt an oral ROTAVIRUS vaccine which was not age appropriate. [give off License]
Approximately 50 mins post vaccine I experienced urticaria of left arm and chin plus itching of face, both arms, scalp and legs.
Bells Palsy/Ramsey Hunt developed 10 to 11 days after vaccination